Medisca Inc recalls CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use…
- Recall date
- February 14, 2014
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0674-2016
- FDA classification
- Class I
- Brand / firm
- Medisca Inc
- Sold / distributed
- Nationwide and Australia
Why it was recalled
Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use and distribution in prescription compounding, manufacturing, processing, or repackaging only in accordance with FDA regulations and applicable law, Packaged by Medisca Inc. Plattsburgh, NY 12901, USA, NDC #s: 38779-1186-4 (25 g), 38779-1186-5 (100 g), 38779-1186-8 (500 g), 38779-1186-9 (1 kg).
Get recall alerts
Free email alert whenever Medisca Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medisca Inc